Biosynth logo

Biosynth

Critical Raw Materials and Services for Diagnostics, Vaccines and Pharmaceuticals

404 employees · est. 1966 · Switzerland

VS
Recursion logo

Recursion

Decoding Biology to Radically Improve Lives

764 employees · est. 2013 · Salt Lake City, United State...

Biosynth is the older company (1966 vs 2013); Recursion is the larger of the two.

Side-by-Side Comparison

Biosynth Recursion
Founded
1966 older 2013
Headquarters
Switzerland Salt Lake City, United States
Employees
404 764 larger
Industry
Manufacturing AI, Biotechnology, Health and Wellness
Funding Stage
Not tracked yet IPO
Total Funding
Not tracked yet $1.30B
Funding Rounds
Not tracked yet 17
Services
Not tracked yet AI-driven solutions in drug discovery, Development of treatments for oncology and rare diseases, Collaborations with pharmaceutical and tech companies, Building and utilizing scalable data models
Target Customers
Not tracked yet Pharmaceutical companies, Biotech researchers, Clinical institutions, Healthcare providers focusing on oncology and rare diseases
Taxonomy
Custom Synthesis, Manufacturing Services, Chemical Supply Chain, Peptide Synthesis, Biological Raw Materials, Enzyme Development, Diagnostic Reagents, Bioconjugation Chemistry, GMP Manufacturing, Life Science Research, Complex Chemicals, Biocatalysis, Pharmaceutical Supply, Diagnostics Support, Global Distribution TechBio, Clinical-stage Biotechnology, Biological And Chemical Datasets, Machine Learning And AI Algorithms, Drug Discovery, Recursion OS, Phenomics, Drug Repurposing, Rare Diseases, Immuno-oncology, Diseases Of Aging, Automation In Biology, Data Science In Healthcare, Neuroscience
Website
biosynth.com recursion.com
Biosynth logo

About Biosynth

Biosynth is a pioneering company that provides critical raw materials and services for diagnostics, vaccines, and pharmaceuticals. Its slogan, "Critical Raw Materials and Services for Diagnostics, Vaccines and Pharmaceuticals", aptly summarizes its core focus. The company's mission centers around su...

Recursion logo

About Recursion

Recursion, a clinical-stage TechBio company established in 2013, is pioneering advancements in biology with its mission to decode biology to radically improve lives. The company, traded on NASDAQ under the ticker RXRX, operates at the intersection of AI, Biotechnology, Health and Wellness, Pharmaceu...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Biosynth and Recursion — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Biosynth and Recursion — by email.

Frequently Asked Questions

Biosynth — Critical Raw Materials and Services for Diagnostics, Vaccines and Pharmaceuticals. Recursion — Decoding Biology to Radically Improve Lives. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Biosynth has raised undisclosed funding while Recursion has raised $1.30B.
Biosynth and Recursion operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Biosynth with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy